Nowatorskie Rozwiązanie w Diagnostyce APEC – Wyniki Badań Naukowych
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains
Proteon Pharmaceuticals uzyskał polski patent na nowe szczepy bakteriofagów stosowanych w akwakulturze
We are excited to announce that our bacteriophage-based technology has been granted patent protection by the Polish Patent Office. The invention, “Bacteriophage strains and their
W Centrum Bakteriofagów: Naukowe Potwierdzenie Skuteczności BAFASAL®
Our research, published in 2020 in Viruses (MDPI), titled ‘Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella
Podsumowanie Naszych Największych Osiągnięć w 2024 Roku
We are pleased to share the significant progress Proteon Pharmaceuticals made in 2024. Our company strengthened its market position, advanced its research initiatives, and expanded
BAFASAL PRO Zarejestrowany na Rynku Brazylijskim
Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based
Skuteczność BAFASAL® Potwierdzona przez Agencję EFSA - Kluczowy Krok w Hodowli Drobiu
Proteon Pharmaceuticals is excited to announce that the European Food Safety Authority (EFSA) has published a positive scientific opinion on our innovative product BAFASAL®. The